Re: IMO, re-validated 148, is a catch all for the other dys1

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Prev Message Back To Forum Threaded View Next Message

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: IMO, re-validated 148, is a catch all for the other dys1

in response to

Re: IMO, re-validated 148, is a catch all for the other dys1

billwilke

posted on Sep 10, 2008 05:21AM

The examiner's rationale for rejecting those new claims is not unfounded. There is a sound basis, which makes fighting it a bit more problematic. And if little or nothing is lost by foregoing those additional claims, why prolong the reexam? They did keep some of the new claims that they felt could be easily defended. IMHO